Clavudale (10 - 20 kg)
Active substance
ATC code
Species
Dogs.
Indications
For the treatment of bacterial infections susceptible to amoxicillin in combination with clavulanic acid where clinical experience and/or sensitivity testing indicates the veterinary medicinal product as the drug of choice.
Uses include:
Skin infections (including deep and superficial pyodermas) associated with
Staphylococcus spp. and Streptococcus spp.;
Infections of the oral cavity (mucous membrane) associated with Clostridium spp.,
Trueperella spp. (previously Corynebacterium spp.), Staphylococcus spp.,
Streptococcus spp., Bacteroides spp. and Pasteurella spp.;
Urinary tract infections associated with Staphylococcus spp., Streptococcus spp.,
Escherichia coli and Proteus mirabilis;
Respiratory tract infections associated with Staphylococcus spp., Streptococcus spp., and Pasteurella spp.
Gastrointestinal infections associated with Escherichia coli and Proteus mirabilis.
Dose to be administered and administration route
For oral administration only. The dosage rate is 10 mg amoxicillin/2.5 mg clavulanic acid/kg body weight twice daily. The tablets may be added to a little food. To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
The following table is intended as a guide to dispensing the veterinary medicinal product at the standard dose rate of 10 mg amoxicillin/2.5 mg clavulanic acid/kg body weight twice daily.
|
Body weight (kg) |
Number of tablets twice daily |
|
> 8 to ≤ 10 |
½ |
|
> 10 to ≤ 20 |
1 |
|
> 20 to ≤ 30 |
1½ |
|
> 30 to ≤ 40 |
2 |
In refractory cases the dose may be doubled to 20 mg amoxicillin/5 mg clavulanic acid/kg body weight twice daily.
Duration of therapy:
Routine cases involving all indications:
The majority of routine cases respond to between 5 and 7 days of therapy. Lack of effect after 5-7 days of treatment necessitates renewed examination.
Chronic or refractory cases:
In chronic cases, longer courses of antibacterial therapy may be required. In such circumstances, overall treatment length is at the clinician’s discretion, but must be long enough to ensure complete resolution of the bacterial disease.
Adverse reactions
Dogs:
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Vomitinga, Diarrhoeaa |
|
Undetermined frequency (cannot be estimated from the available data) |
Blood dyscrasia, Colitis Anaphylaxis, Allergic skin reaction |
a Mild. In these cases, discontinue administration and give symptomatic therapy.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-VReferences
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 10434/5014 |
| EAN | 5701170422559 |
Similar products
Showing 5 of 5 results
Clavudale (10 - 20 kg)
Clavudale (10 - 20 kg)
Clavudale (10 - 20 kg)
Clavudale (10 - 20 kg)
